JPH032848B2 - - Google Patents

Info

Publication number
JPH032848B2
JPH032848B2 JP56159562A JP15956281A JPH032848B2 JP H032848 B2 JPH032848 B2 JP H032848B2 JP 56159562 A JP56159562 A JP 56159562A JP 15956281 A JP15956281 A JP 15956281A JP H032848 B2 JPH032848 B2 JP H032848B2
Authority
JP
Japan
Prior art keywords
hydrogen
polyethylene glycol
composition according
lower alkyl
polyoxyethylene sorbitan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56159562A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5793911A (en
Inventor
Enrike Garootoresu Fuugoo
Eichi Shaa Nabunito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EFU HOFUMAN RA ROSHU AG
Original Assignee
EFU HOFUMAN RA ROSHU AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EFU HOFUMAN RA ROSHU AG filed Critical EFU HOFUMAN RA ROSHU AG
Publication of JPS5793911A publication Critical patent/JPS5793911A/ja
Publication of JPH032848B2 publication Critical patent/JPH032848B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP56159562A 1980-10-09 1981-10-08 Drug composition Granted JPS5793911A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/195,575 US4310543A (en) 1980-10-09 1980-10-09 Prostaglandin compositions

Publications (2)

Publication Number Publication Date
JPS5793911A JPS5793911A (en) 1982-06-11
JPH032848B2 true JPH032848B2 (https=) 1991-01-17

Family

ID=22721933

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56159562A Granted JPS5793911A (en) 1980-10-09 1981-10-08 Drug composition

Country Status (13)

Country Link
US (1) US4310543A (https=)
EP (1) EP0049852B1 (https=)
JP (1) JPS5793911A (https=)
AT (1) ATE14981T1 (https=)
AU (1) AU547175B2 (https=)
CA (1) CA1176567A (https=)
DE (1) DE3171928D1 (https=)
DK (1) DK442881A (https=)
IE (1) IE51637B1 (https=)
IL (1) IL63960A (https=)
NZ (1) NZ198533A (https=)
PH (1) PH17073A (https=)
ZA (1) ZA816852B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1695783A (en) * 1982-07-19 1984-01-26 Syntex (U.S.A.) Inc. Encapsulated pge type compositions
US4431833A (en) * 1982-12-27 1984-02-14 American Cyanamid Company Prostaglandin and hydroxylated fatty acid ester formulations
FR2549371B1 (fr) * 1983-07-20 1985-09-13 Sanofi Sa Nouvelle composition pharmaceutique contenant de l'acide valproique ou un de ses sels
KR850700213A (ko) * 1984-02-08 1985-12-26 제이.데스몬드 다비스 아세트 아미노펜 젤라틴 캡슐
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
NO882653D0 (no) * 1988-06-15 1988-06-15 Apothekernes Lab Doseringsform.
US5208256A (en) * 1990-05-22 1993-05-04 R-Tech Ueno, Ltd. Treatment of ocular hypertension with a synergistic combination for ocular administration
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US6180666B1 (en) 1997-09-05 2001-01-30 Anmax, Inc. Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
US5962522A (en) * 1997-09-05 1999-10-05 Avmax, Inc. Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
WO2001003695A1 (en) * 1999-07-13 2001-01-18 Avmax, Inc. Improvement of bioavailability with vitamin c fatty acid esters
KR100649860B1 (ko) * 2000-09-01 2006-11-24 주식회사종근당 알프로스타딜 경점막 및 경피흡수제제
CA2422031C (en) * 2000-09-13 2011-11-15 Santen Pharmaceutical Co., Ltd. Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
WO2005011704A1 (ja) * 2003-07-31 2005-02-10 Santen Pharmaceutical Co., Ltd. プロスタグランジン含有製品
KR101152470B1 (ko) 2003-08-13 2012-06-01 바이오콘 리미티드 치료제용 마이크로-입자 지방산 염 고형 투약 제형
EP1675548A4 (en) * 2003-09-25 2008-08-13 Activbiotics Inc RIFALAZIL FORMULATIONS
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
CN102526064A (zh) * 2004-12-09 2012-07-04 参天制药株式会社 含有分子内具有氟原子的前列腺素的制品
WO2006068266A1 (ja) * 2004-12-24 2006-06-29 Santen Pharmaceutical Co., Ltd. プロスタグランジンＦ２ａ誘導体含有製品
CA2651159A1 (en) * 2006-04-06 2007-10-18 Activbiotics Pharma Llc Pharmaceutical compositions and uses thereof
EP2327398A3 (en) 2007-07-19 2014-05-21 R-Tech Ueno, Ltd. Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound
EP2214635A1 (en) * 2007-10-19 2010-08-11 Purdue Research Foundation Solid formulations of crystalline compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2889252A (en) * 1956-05-14 1959-06-02 American Cyanamid Co Gelatin capsule containing hexylresorcinol and a lower polyalkylene glycol
ZA721937B (en) * 1971-10-22 1972-12-27 Upjohn Co Pharmaceutical preparations and uses thereof
CA1043259A (en) * 1972-12-08 1978-11-28 Geoffrey F. Thompson Medicament preparations and vehicles therefor
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations
US4052446A (en) * 1973-08-06 1977-10-04 Hoffmann-La Roche Inc. 11,16-substituted prostaglandins
JPS6019734B2 (ja) * 1977-05-12 1985-05-17 三共株式会社 安定なプロスタグランジンｅ類製剤の製法
JPS6046094B2 (ja) * 1977-06-01 1985-10-14 科研製薬株式会社 安定化されたプロスタグランジンｅ類粉末製剤
FI790043A7 (fi) * 1978-01-17 1979-07-18 Sandoz Ag Prostaglandiner innehaollande terapeutisk sammansaettning

Also Published As

Publication number Publication date
AU7606881A (en) 1982-04-22
EP0049852A3 (en) 1983-01-26
ATE14981T1 (de) 1985-09-15
JPS5793911A (en) 1982-06-11
EP0049852A2 (de) 1982-04-21
US4310543A (en) 1982-01-12
PH17073A (en) 1984-05-24
IL63960A (en) 1985-05-31
DK442881A (da) 1982-04-10
IE812354L (en) 1982-04-09
ZA816852B (en) 1982-09-29
EP0049852B1 (de) 1985-08-21
AU547175B2 (en) 1985-10-10
IE51637B1 (en) 1987-01-21
CA1176567A (en) 1984-10-23
IL63960A0 (en) 1981-12-31
NZ198533A (en) 1984-12-14
DE3171928D1 (en) 1985-09-26

Similar Documents

Publication Publication Date Title
JPH032848B2 (https=)
CA1203172A (en) Propylene glycol diester solutions of pge-type compounds
EP0063367B1 (en) Acetal stabilized prostaglandin compositions
EP0058418B1 (en) Carbonate diester solutions of pge-type compounds
US4410545A (en) Carbonate diester solutions of PGE-type compounds
DE69824277T2 (de) Stabile medizinische zusammenstellungen die 4,5-epoxymorphinanderivate enthalten
EP0349235A2 (en) Niacin and guar-gum containing composition
US5491171A (en) Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration
JP2003503339A (ja) 抗癌剤を含有する自己乳化システム
US4623641A (en) Method of treating ulcers and erosions in the gastrointestinal system using PGI2 -methyl ester-beta cyclodextrin inclusion complexes
US4784855A (en) Pharmaceutical compositions and suppository
CA1216793A (en) Pge-type compositions encapsulated by acid isolated gelatin
WO2021099901A1 (en) Stable topical pharmaceutical composition
JP2812683B2 (ja) 持続性を有するモルヒネ直腸投与製剤
EP0535704A1 (en) Glycyrrhizin suppository
CS208779B2 (en) Method of stabilization of the 4-methyl-5-/2'-chlorethyl/thiazole
JP2885668B2 (ja) テプレノン製剤
JPS631923B2 (https=)
JP3174595B2 (ja) 坐 剤
WO1994011017A1 (fr) Preparation buvable
JPH08208598A (ja) プロスタグランジン類組成物
JPWO1994011017A1 (ja) 経口投与用製剤